File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Reply: Aspirin and GLP-1RAs-the missing confounders of empagliflozin for MASLD without diabetes mellitus?

TitleReply: Aspirin and GLP-1RAs-the missing confounders of empagliflozin for MASLD without diabetes mellitus?
Authors
Issue Date1-Jan-2024
PublisherLippincott, Williams & Wilkins
Citation
Hepatology, 2024 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/350802
ISSN
2023 Impact Factor: 12.9
2023 SCImago Journal Rankings: 5.011

 

DC FieldValueLanguage
dc.contributor.authorCheung, Ka Shing-
dc.contributor.authorLeung, Wai K.-
dc.date.accessioned2024-11-03T00:30:30Z-
dc.date.available2024-11-03T00:30:30Z-
dc.date.issued2024-01-01-
dc.identifier.citationHepatology, 2024-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/350802-
dc.languageeng-
dc.publisherLippincott, Williams & Wilkins-
dc.relation.ispartofHepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleReply: Aspirin and GLP-1RAs-the missing confounders of empagliflozin for MASLD without diabetes mellitus?-
dc.typeArticle-
dc.identifier.doi10.1097/HEP.0000000000001034-
dc.identifier.pmid39047080-
dc.identifier.scopuseid_2-s2.0-85199722695-
dc.identifier.eissn1527-3350-
dc.identifier.issnl0270-9139-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats